Physician-reported barriers and strategies to using tumor mutational burden (TMB) testing in oncology care: An interview based study. From seed to harvest: 18-month experience of molecular tumor board ...
Reston, VA (August 20, 2024) —A new molecular imaging technique that pairs a novel tracer with a next-generation PET/CT scanner can identify neuroblastoma in children with high sensitivity, requiring ...
A pilot clinical study evaluated a novel PET/CT tracer, ⁶⁸Ga-DOTA-MGS5, targeting cholecystokinin-2 receptors in patients with advanced medullary thyroid cancer (MTC) and neuroendocrine tumors (NETs).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results